November 15, 2021 Comments Off on New patent expiration for Novartis drug AMTURNIDE Posted in: Uncategorized
Annual Drug Patent Expirations for AMTURNIDE Amturnide is a drug marketed by Novartis and is included in one NDA. There are two patents protecting this drug. This drug has one…
The post New patent expiration for Novartis drug AMTURNIDE appeared first o…
November 14, 2021 Comments Off on Drug Patent Expirations for the Week of November 14, 2021 Posted in: Uncategorized
ASACOL HD (mesalamine) Apil Patent: 9,089,492 Expiration: Nov 15, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Patent Expi…